UT Southwestern, Children's Medical Center to test new rapid diagnostic equipment

October 31, 2002

DALLAS - Oct. 31, 2002 - Instead of waiting five to seven days to find out if a child brought to the emergency room tests positive for meningitis or whooping cough, new rapid diagnostic testing equipment will provide doctors at UT Southwestern Medical Center at Dallas and Children's Medical Center of Dallas with an answer in a few hours.

A one-year, $435,000 grant from the Centers for Disease Control and Prevention to Children's will allow UT Southwestern researchers to develop protocols, procedures and reagents using a thermocycler called GeneXpert. The automated device, which rapidly processes and analyzes DNA samples, is manufactured by Cepheid of California.

With the new equipment, doctors will be able to quickly diagnose infectious diseases in children brought to the emergency room. Results would be available within hours rather than the five to seven days needed for a culture.

"With the capability of rapid turnaround and ease of DNA testing, the tests could be done seven days a week, 24 hours a day, and even at the patient's bedside," said Dr. Beverly Rogers, professor of pathology at UT Southwestern and chief of pathology at Children's. "This is not possible with current methods.

"This provides high-tech testing capabilities. This instrument allows a health-care worker to take a swab from a patient, dip it in solution, place it in the instrument and walk away. This is bringing molecular diagnoses into the clinical laboratory."

The new testing methods should allow children to leave the hospital sooner, or even avoid hospitalization altogether, Rogers said.

Research will focus on developing rapid testing for enterovirus and herpes simplex virus, both of which cause meningitis, and Bordetella pertussis, the bacterium that causes whooping cough.

"Having this grant and collaborating with Cepheid will allow us to march rapidly forward with the development of these tests," said Rogers.

Funding for the project began in August and the new equipment will be delivered in November.

Last year at Children's Medical Center, about 350 patients were tested for whooping cough and about 200 for meningitis.

The laboratory for molecular diagnosis in the Department of Pathology at UT Southwestern and Children's will work jointly on the project.
-end-
To automatically receive news releases from UT Southwestern via e-mail, go to http://www3.utsouthwestern.edu/ and click on "Latest News." Then go to "Receive our News" to subscribe.

UT Southwestern Medical Center

Related Whooping Cough Articles from Brightsurf:

Tracking flight trajectory of evaporating cough droplets
The ongoing COVID-19 pandemic has led many to study airborne droplet transmission in different conditions and environments, and in Physics of Fluids, researchers from A*STAR conducted a numerical study on droplet dispersion using high fidelity air flow simulation.

COVID-19 cough clouds in closed spaces
As the pandemic continues, researchers have increasingly focused on how respiratory droplets carrying the coronavirus travel and contaminate the air after an infected person coughs.

The good cough and the bad cough
Researchers might be able to treat a troublesome cough in disease without disrupting the protective cough we need for optimal lung health, by targeting the different brain circuits involved.

Whooping cranes form larger flocks as wetlands are lost -- and it may put them at risk
Over the past few decades, the endangered whooping crane (Grus Americana) has experienced considerable recovery.

Trials show new drug can ease symptoms of chronic cough
Two trials of a new drug have shown that at low doses, it can ease the often distressing symptoms of chronic cough with minimal side effects.

The Lancet Respiratory Medicine: New therapy could help relieve persistent cough
A new treatment - called gefapixant - may reduce the frequency of coughing, including in patients who have suffered from a chronic cough for more than 15 years, according to results from a phase 2b clinical trial which lasted 12 weeks and included 253 people, published in The Lancet Respiratory Medicine journal.

Shortness of breath and cough increase as first symptom of lung cancer
GPs are being urged to consider shortness of breath and cough as potential predictors of lung cancer, after a study found they were becoming more common as the first symptom in diagnosis.

Whooping cough evolving into a superbug
Whooping cough bacteria are becoming smarter at colonising and feeding off unwitting hosts -- whether they have been vaccinated or not -- strengthening calls for a new vaccine, according to UNSW researchers.

Doctors more likely to recommend antihistamines rather than cough & cold medicine for kids
For respiratory infections in children under 12, physicians are increasingly more likely to recommend antihistamines and less likely to recommend cough and cold medicines, a Rutgers study found.

Waning potency of pertussis vaccine a significant contributor to recent whooping cough outbreaks
New Kaiser Permanente study suggests under-vaccination is only one factor contributing to whooping cough outbreaks.

Read More: Whooping Cough News and Whooping Cough Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.